Current Report Filing (8-k)
September 16 2020 - 8:00AM
Edgar (US Regulatory)
0001076682
false
false
0001076682
2020-09-16
2020-09-16
0001076682
PTE:CommonStockParValue0.001Member
2020-09-16
2020-09-16
0001076682
PTE:PreferredStockPurchaseRightsMember
2020-09-16
2020-09-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September
16, 2020
POLARITYTE,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-32404
|
|
06-1529524
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
1960
S. 4250 West, Salt Lake City, UT 84104
(Address
of principal executive offices and zip code)
Registrant’s
telephone number, including area code: (800) 560-3983
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
Common
Stock, Par Value $0.001
|
|
PTE
|
|
Nasdaq
Capital Market
|
Preferred
Stock Purchase Rights
|
|
|
|
Nasdaq
Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On
September 16, 2020, PolarityTE, Inc. (the “Company”) issued a press release titled “SkinTE™ Health
Economics - DFU Interim Analysis Data Demonstrates Potential for Cost Savings and Improved Wound Closure,” announcing cost
per product data from the protocol-specified interim analysis in the Company’s ongoing randomized controlled trial evaluating
SkinTE™. A copy of the press release is filed herewith as Exhibit 99.1.
Item
9.01
|
Financial
Statements and Exhibits.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
POLARITYTE,
INC.
|
|
|
Dated:
September 16, 2020
|
/s/
Jacob Patterson
|
|
Jacob
Patterson
|
|
Interim
Chief Financial Officer
|
PolarityTE (NASDAQ:PTE)
Historical Stock Chart
From Mar 2024 to Apr 2024
PolarityTE (NASDAQ:PTE)
Historical Stock Chart
From Apr 2023 to Apr 2024